# Mucopolysaccharidosis
What is it
Mucopolysaccharidosis (often abbreviated as MPS) is a rare inherited metabolic disorder. The body cannot break down certain large sugar molecules (polysaccharides). These accumulate in cells, particularly in connective tissue, bones, organs, and the nervous system. This causes gradual damage to many bodily functions.
There are more than ten different types of MPS, numbered from type I to XI. Each type is caused by a deficiency of a different enzyme. Most types are inherited via an autosomal-recessive pattern (both parents carry the gene), although some are inherited through the X chromosome. The severity and pattern of symptoms vary greatly by type.
MPS is usually discovered in early childhood, though some forms may not become apparent until later. In the Netherlands and Belgium they are rare diseases; there are more diagnoses in larger countries, but everywhere MPS remains a disease requiring specific expertise.
Causes
MPS develops because a gene that codes for an enzyme in the lysosome (a small organelle in cells that acts as a waste processor) does not function properly. Without this working enzyme, certain sugar chains cannot be broken down. They accumulate in lysosomes of numerous cells.
Which enzyme is missing determines which type of MPS a person has. The genetic cause is congenital; you inherit it from your parents, usually without them being ill themselves (carriers).
A child gets MPS only if they inherit the defective gene from both parents (or in X-linked forms: from the mother, in boys). This can occur entirely unexpectedly, even if no case is known in the family.
How the disease progresses
Most forms of MPS begin showing symptoms in babyhood or early childhood, although some do not become apparent until school years or the teenage years.
The disease progresses gradually. Body cells become more burdened as more waste products accumulate. This leads to increasing problems with skeleton, heart, lungs, eyes, ears, and (in many types) the brain.
**Rate of progression:**
- Some types (for example MPS I severe, MPS II, MPS III) progress relatively quickly and can lead to serious limitations in youth.
- Other types (for example MPS IV, certain forms of MPS I) progress more slowly and allow more time before serious problems arise.
- A small number of types (MPS VI and VII) can even remain reasonably stable for decades.
In all cases, however, progression is the rule: symptoms worsen not suddenly, but step by step.
Symptoms by phase
**Early (usually first months of life to year 1–2):**
- Growth delay or normal growth initially, followed by slowing
- Swollen belly, sometimes enlarged heart or liver
- Thickening facial features
- Possible ear or eye problems
- In some types: neurological signs (developmental milestones not being met)
**Middle (approximately year 2–10, depending on type):**
- Progressive skeletal deformities (short neck, curved spine, stiff joints)
- Growth delay becomes more obvious
- Heart problems may manifest (thickening of heart valves)
- Hearing loss, sometimes severe visual problems
- In neurological types: developmental delay or loss, behavioral changes
- Increased susceptibility to infection and lung problems
- Possible compression of nerve pathways (for example in the neck)
**Late (year 10+, highly dependent on type):**
- Severe skeletal disorders, limited mobility
- Heart failure or damaged heart valves
- Severe lung disease in some types
- In progressive neurological types: progressive cognitive decline, loss of skills
- Increased risk of complications (infections, breathing problems)
The exact pattern depends on which type of MPS and how quickly that type progresses.
What it means for daily life
**Family and parenting:**
Parents and siblings undergo major changes. Much time is needed for hospital visits, therapies and daily care. For the child: depending on the type and stage, school, play and friendships can be greatly hindered by physical limitations, hearing problems, vision problems or cognitive challenges.
**Movement and mobility:**
Many MPS patients experience stiffness, joint pain and progressive immobility. This requires regular physiotherapy. Aids (walker, wheelchair) often become necessary at some point.
**School and work:**
Children may (depending on type) have difficulty with concentration, hearing or sight, or miss many school days due to treatment. Adults with slower types may be able to do paid work, but will usually need adjustments.
**Heart, lungs and infections:**
Some MPS patients have chronic lung problems or heart valve dysfunction. This can lead to fatigue and shortness of breath. Infections (respiratory infections, ear infections) are more common.
**Nutrition and digestion:**
Some have difficulty swallowing or digestion. Dietary guidance may be needed.
**Self-image and mental wellbeing:**
External changes (facial features, body posture) and growth delay can be emotionally difficult, especially in the teenage years.
Outlook
The outlook depends heavily on which type of MPS and how quickly that type progresses.
**Rapid types (e.g. MPS I severe, MPS II, MPS III):**
Without treatment, these usually lead to severe limitations and life expectancy can remain short. Medical complications (heart problems, lung diseases) are major risk factors.
**Slower types (e.g. MPS IV, VI, VII):**
With good medical care, many patients can become adolescents and adults, though with increasing physical limitations.
**Effect of treatment:**
For some types (MPS I, II, VI, VII), enzyme replacement therapies are available. These slow progression, especially if started early, but do not cure. Stem cell therapy (bone marrow transplant) has been investigated in some cases and can reduce certain symptoms, but is an invasive procedure with risks.
**Life expectancy:**
Population figures (mostly from 2010–2020) show that patients with untreated rapid types die on average in their teenage years. With slower types, many people can become thirty, forty or older. However: these figures say nothing about one individual. Individuals can do better or worse than the average, depending on, among other things, the exact genetic variant, care and complications.
**Early diagnosis and start of treatment** (where available) improve the outlook, especially for neurological progression.
Frequently asked questions
**Can MPS be cured?**
Not so far with a classical "cure". Enzyme replacement and stem cell therapy can slow or improve some symptoms, but do not cure the underlying genetic defect. Research into gene therapy is underway in some countries, but is not yet standard. Treatment now focuses mainly on symptom management and preventing complications.
**How is MPS diagnosed?**
Usually through a combination of clinical recognition (appearance, growth, symptoms), enzyme tests in blood or urine, and genetic testing. In newborns, screening programs (newborn screening) can sometimes detect it early. Patients are usually referred to a medical geneticist or metabolic disease specialist.
**Can brothers or sisters also get MPS?**
Yes, if both parents are carriers of the same gene. The chance is then 25% per child. If one parent is a carrier and the other is not, children can become carriers but will usually not be ill. Genetic counseling helps families better understand these risks.
**What is the difference between all types of MPS?**
Each type is caused by the deficiency of a different enzyme, leading to different patterns of accumulation and other symptom profiles. Type I primarily affects connective tissue and brain; type II affects only boys; type III primarily affects the brain; type IV primarily affects bones and eyes; etc. This difference determines which specialists are involved and which treatments are available.
---
_This information never replaces a doctor's judgment. Always discuss your situation with your own healthcare provider._